Authors

• Cynthia Deignan
• Andreas Pinter (ORCID: https://orcid.org/0000-0002-1330-1502)
• Jacob Aelion (ORCID: https://orcid.org/0000-0001-5727-7199)
• Rebecca Wang (ORCID: https://orcid.org/0000-0002-8775-9567)
• Yuri M. Klyachkin
• Joseph Frank Merola (ORCID: https://orcid.org/0000-0001-6514-4353)
• Dafna D. Gladman (ORCID: https://orcid.org/0000-0002-9074-0592)
• Jyotsna Reddy
• Philip J. Mease (ORCID: https://orcid.org/0000-0002-6620-0457)
• Jitendra Vasandani
• Laura C. Coates (ORCID: https://orcid.org/0000-0002-4756-663X)
• Laure Gossec (ORCID: https://orcid.org/0000-0002-4528-310X)
• Arthur Kavanaugh (ORCID: https://orcid.org/0000-0001-6942-5830)
• Michèle Brunori

Institutions

• Goethe University Frankfurt (DE)
• Amgen (United States) (US)
• Inserm (FR)
• Providence College (US)
• University of Washington (US)
• Toronto Western Hospital (CA)
• Nuffield Orthopaedic Centre (GB)
• University of California San Diego (US)
• Sorbonne Université (FR)
• University of Oxford (GB)
• Swedish Medical Center (US)
• Assistance Publique – Hôpitaux de Paris (FR)
• Middle Tennessee Research Institute (US)
• Pitié-Salpêtrière Hospital (FR)
• Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
• Krembil Research Institute
• Southwestern Medical Center (US)
• The University of Texas Southwestern Medical Center (US)

Publication Details

Journal

Annals of the Rheumatic Diseases

Published

2024-08-20

DOI

https://doi.org/10.1136/ard-2024-225833

Citations

8

Primary Topic

Spondyloarthritis Studies and Treatments

Type

article

Field-Weighted Citation Impact

3.76

Funders

• Amgen
• Bristol-Myers Squibb
• Eli Lilly and Company
• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Sanofi
• Gilead Sciences
• Biogen
• Celgene
• National Institute for Health and Care Research
• Novo Nordisk
• Genentech